Grown Rogue International (GRUSF) Capital Expenditures Growth (3y) (2021 - 2023)
Grown Rogue International (GRUSF) Capital Expenditures Growth (3y) (2021 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -4.39% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -11.01% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.22% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 34.19% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -8.00% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 4.68% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -7.72% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -227.37% |
| Jul 31, 2023 | -75.61% |
| Apr 30, 2023 | -50.43% |
| Jan 31, 2023 | -115.69% |
| Jan 31, 2022 | -93.71% |
| Oct 31, 2021 | -31.64% |
| Jul 31, 2021 | -174.63% |
| Apr 30, 2021 | 72.15% |
| Jan 31, 2021 | 30.47% |